Skip to content

Clinical trials

Phase 2 Cystic Fibrosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cystic Fibrosis Phase: Phase 2 Country / region: United States Clear all

103 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20032
20042
20054
20061
20073
20088
20093
20107
20114
20125
20133
20143
20155
20168
20178
20184
20198
20201
20214
20223
20232
20245
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed78
Terminated11
Recruiting9
Unknown status2
Active, not recruiting1
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Vertex Pharmaceuticals Incorporated16
Boehringer Ingelheim4
Entero Therapeutics3
Gilead Sciences3
University of Kansas Medical Center3
University of North Carolina, Chapel Hill3
AbbVie2
Augusta University2
Bayer2
Children's Hospitals and Clinics of Minnesota2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cystic Fibrosis103
Exocrine Pancreatic Insufficiency9
Lung Diseases7
Genetic Diseases, Inborn5
Pancreatic Diseases4
Pseudomonas Infections4
Respiratory Tract Diseases4
Infant, Newborn, Diseases3
Inflammation3
Bronchiectasis2

Trials

Showing 1 to 25 of 103. Each trial links to its page on Pharma Observatory.

3 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.